nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—head and neck cancer	0.858	1	CbGaD
Diflunisal—Niclosamide—STAT3—head and neck cancer	0.00962	0.688	CrCbGaD
Diflunisal—UGT1A8—tongue—head and neck cancer	0.00839	0.265	CbGeAlD
Diflunisal—UGT1A8—mouth—head and neck cancer	0.00564	0.178	CbGeAlD
Diflunisal—Gastrointestinal perforation—Docetaxel—head and neck cancer	0.00399	0.0536	CcSEcCtD
Diflunisal—Peptic ulcer—Vinblastine—head and neck cancer	0.00329	0.0442	CcSEcCtD
Diflunisal—PTGS2—cartilage tissue—head and neck cancer	0.00222	0.0702	CbGeAlD
Diflunisal—TTR—neck—head and neck cancer	0.00221	0.07	CbGeAlD
Diflunisal—UGT1A8—head—head and neck cancer	0.00204	0.0644	CbGeAlD
Diflunisal—UGT1A8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00194	0.0881	CbGpPWpGaD
Diflunisal—TTR—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.00192	0.0873	CbGpPWpGaD
Diflunisal—Deafness—Vinblastine—head and neck cancer	0.00178	0.0239	CcSEcCtD
Diflunisal—Disorientation—Hydroxyurea—head and neck cancer	0.00163	0.0218	CcSEcCtD
Diflunisal—TTR—connective tissue—head and neck cancer	0.00159	0.0502	CbGeAlD
Diflunisal—UGT1A8—Phase II conjugation—NAT2—head and neck cancer	0.00132	0.0598	CbGpPWpGaD
Diflunisal—Photosensitivity—Fluorouracil—head and neck cancer	0.00119	0.016	CcSEcCtD
Diflunisal—Dysuria—Hydroxyurea—head and neck cancer	0.00118	0.0158	CcSEcCtD
Diflunisal—Disorientation—Fluorouracil—head and neck cancer	0.00117	0.0157	CcSEcCtD
Diflunisal—TTR—lymphoid tissue—head and neck cancer	0.00116	0.0367	CbGeAlD
Diflunisal—Agranulocytosis—Vinblastine—head and neck cancer	0.00115	0.0154	CcSEcCtD
Diflunisal—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—head and neck cancer	0.00112	0.0508	CbGpPWpGaD
Diflunisal—Hearing impaired—Docetaxel—head and neck cancer	0.00109	0.0147	CcSEcCtD
Diflunisal—Stomatitis—Hydroxyurea—head and neck cancer	0.00109	0.0147	CcSEcCtD
Diflunisal—TTR—thyroid gland—head and neck cancer	0.00105	0.0333	CbGeAlD
Diflunisal—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00105	0.0141	CcSEcCtD
Diflunisal—Hallucination—Hydroxyurea—head and neck cancer	0.001	0.0134	CcSEcCtD
Diflunisal—Olsalazine—PTGS2—head and neck cancer	0.000968	0.0693	CrCbGaD
Diflunisal—TTR—head—head and neck cancer	0.000935	0.0296	CbGeAlD
Diflunisal—Lightheadedness—Docetaxel—head and neck cancer	0.000931	0.0125	CcSEcCtD
Diflunisal—Aminosalicylic Acid—PTGS2—head and neck cancer	0.00091	0.0651	CrCbGaD
Diflunisal—PTGS2—mouth—head and neck cancer	0.000901	0.0285	CbGeAlD
Diflunisal—Vertigo—Vinblastine—head and neck cancer	0.000863	0.0116	CcSEcCtD
Diflunisal—Deafness—Docetaxel—head and neck cancer	0.000845	0.0113	CcSEcCtD
Diflunisal—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000826	0.0111	CcSEcCtD
Diflunisal—Salsalate—PTGS2—head and neck cancer	0.000823	0.0589	CrCbGaD
Diflunisal—Visual disturbance—Docetaxel—head and neck cancer	0.000797	0.0107	CcSEcCtD
Diflunisal—Renal impairment—Docetaxel—head and neck cancer	0.000794	0.0107	CcSEcCtD
Diflunisal—Stomatitis—Fluorouracil—head and neck cancer	0.000786	0.0106	CcSEcCtD
Diflunisal—UGT1A8—Biological oxidations—NAT2—head and neck cancer	0.000771	0.035	CbGpPWpGaD
Diflunisal—Thrombocytopenia—Vinblastine—head and neck cancer	0.000767	0.0103	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000756	0.0102	CcSEcCtD
Diflunisal—Agranulocytosis—Fluorouracil—head and neck cancer	0.000753	0.0101	CcSEcCtD
Diflunisal—Anorexia—Vinblastine—head and neck cancer	0.000747	0.01	CcSEcCtD
Diflunisal—Oedema—Hydroxyurea—head and neck cancer	0.000715	0.0096	CcSEcCtD
Diflunisal—Mesalazine—PTGS2—head and neck cancer	0.000714	0.0511	CrCbGaD
Diflunisal—Paraesthesia—Vinblastine—head and neck cancer	0.000704	0.00946	CcSEcCtD
Diflunisal—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0007	0.0094	CcSEcCtD
Diflunisal—Anorexia—Hydroxyurea—head and neck cancer	0.000681	0.00915	CcSEcCtD
Diflunisal—Decreased appetite—Vinblastine—head and neck cancer	0.000681	0.00915	CcSEcCtD
Diflunisal—Cramp muscle—Docetaxel—head and neck cancer	0.00068	0.00914	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00068	0.00914	CcSEcCtD
Diflunisal—Constipation—Vinblastine—head and neck cancer	0.00067	0.009	CcSEcCtD
Diflunisal—UGT1A8—Phase II conjugation—GSTM1—head and neck cancer	0.000651	0.0295	CbGpPWpGaD
Diflunisal—Feeling abnormal—Vinblastine—head and neck cancer	0.000646	0.00868	CcSEcCtD
Diflunisal—Bronchospasm—Docetaxel—head and neck cancer	0.000642	0.00863	CcSEcCtD
Diflunisal—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000641	0.00861	CcSEcCtD
Diflunisal—Dyspnoea—Hydroxyurea—head and neck cancer	0.000637	0.00856	CcSEcCtD
Diflunisal—Somnolence—Hydroxyurea—head and neck cancer	0.000635	0.00854	CcSEcCtD
Diflunisal—Dyspepsia—Hydroxyurea—head and neck cancer	0.000629	0.00845	CcSEcCtD
Diflunisal—Decreased appetite—Hydroxyurea—head and neck cancer	0.000621	0.00835	CcSEcCtD
Diflunisal—Fatigue—Hydroxyurea—head and neck cancer	0.000616	0.00828	CcSEcCtD
Diflunisal—Constipation—Hydroxyurea—head and neck cancer	0.000611	0.00821	CcSEcCtD
Diflunisal—Vision blurred—Fluorouracil—head and neck cancer	0.000594	0.00798	CcSEcCtD
Diflunisal—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000589	0.00791	CcSEcCtD
Diflunisal—Hypersensitivity—Vinblastine—head and neck cancer	0.000577	0.00776	CcSEcCtD
Diflunisal—PTGS1—connective tissue—head and neck cancer	0.000577	0.0183	CbGeAlD
Diflunisal—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000577	0.00775	CcSEcCtD
Diflunisal—Renal failure—Docetaxel—head and neck cancer	0.000572	0.00769	CcSEcCtD
Diflunisal—Jaundice—Docetaxel—head and neck cancer	0.000568	0.00762	CcSEcCtD
Diflunisal—Stomatitis—Docetaxel—head and neck cancer	0.000568	0.00762	CcSEcCtD
Diflunisal—Body temperature increased—Hydroxyurea—head and neck cancer	0.000565	0.00759	CcSEcCtD
Diflunisal—Asthenia—Vinblastine—head and neck cancer	0.000562	0.00755	CcSEcCtD
Diflunisal—PTGS2—connective tissue—head and neck cancer	0.000552	0.0175	CbGeAlD
Diflunisal—PTGS1—epithelium—head and neck cancer	0.000548	0.0173	CbGeAlD
Diflunisal—Agranulocytosis—Docetaxel—head and neck cancer	0.000543	0.0073	CcSEcCtD
Diflunisal—Chest pain—Fluorouracil—head and neck cancer	0.000537	0.00721	CcSEcCtD
Diflunisal—Diarrhoea—Vinblastine—head and neck cancer	0.000536	0.0072	CcSEcCtD
Diflunisal—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000527	0.00707	CcSEcCtD
Diflunisal—PTGS2—epithelium—head and neck cancer	0.000524	0.0166	CbGeAlD
Diflunisal—Hepatitis—Docetaxel—head and neck cancer	0.000523	0.00702	CcSEcCtD
Diflunisal—Confusional state—Fluorouracil—head and neck cancer	0.000519	0.00697	CcSEcCtD
Diflunisal—Dizziness—Vinblastine—head and neck cancer	0.000518	0.00696	CcSEcCtD
Diflunisal—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000514	0.00691	CcSEcCtD
Diflunisal—Oedema—Fluorouracil—head and neck cancer	0.000514	0.00691	CcSEcCtD
Diflunisal—Asthenia—Hydroxyurea—head and neck cancer	0.000513	0.00689	CcSEcCtD
Diflunisal—Salicylic acid—PTGS2—head and neck cancer	0.000506	0.0362	CrCbGaD
Diflunisal—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000504	0.00677	CcSEcCtD
Diflunisal—Visual impairment—Docetaxel—head and neck cancer	0.000504	0.00677	CcSEcCtD
Diflunisal—Vomiting—Vinblastine—head and neck cancer	0.000498	0.00669	CcSEcCtD
Diflunisal—Erythema multiforme—Docetaxel—head and neck cancer	0.000494	0.00664	CcSEcCtD
Diflunisal—Headache—Vinblastine—head and neck cancer	0.000491	0.0066	CcSEcCtD
Diflunisal—Anorexia—Fluorouracil—head and neck cancer	0.00049	0.00659	CcSEcCtD
Diflunisal—Diarrhoea—Hydroxyurea—head and neck cancer	0.000489	0.00657	CcSEcCtD
Diflunisal—Flushing—Docetaxel—head and neck cancer	0.000485	0.00652	CcSEcCtD
Diflunisal—PTGS1—trachea—head and neck cancer	0.000485	0.0153	CbGeAlD
Diflunisal—Dizziness—Hydroxyurea—head and neck cancer	0.000473	0.00635	CcSEcCtD
Diflunisal—Nausea—Vinblastine—head and neck cancer	0.000466	0.00625	CcSEcCtD
Diflunisal—Insomnia—Fluorouracil—head and neck cancer	0.000465	0.00625	CcSEcCtD
Diflunisal—PTGS2—trachea—head and neck cancer	0.000463	0.0147	CbGeAlD
Diflunisal—Paraesthesia—Fluorouracil—head and neck cancer	0.000462	0.00621	CcSEcCtD
Diflunisal—Dyspnoea—Fluorouracil—head and neck cancer	0.000459	0.00616	CcSEcCtD
Diflunisal—Somnolence—Fluorouracil—head and neck cancer	0.000457	0.00614	CcSEcCtD
Diflunisal—ALB—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.000457	0.0207	CbGpPWpGaD
Diflunisal—Vomiting—Hydroxyurea—head and neck cancer	0.000454	0.00611	CcSEcCtD
Diflunisal—Dyspepsia—Fluorouracil—head and neck cancer	0.000453	0.00608	CcSEcCtD
Diflunisal—Rash—Hydroxyurea—head and neck cancer	0.000451	0.00605	CcSEcCtD
Diflunisal—Dermatitis—Hydroxyurea—head and neck cancer	0.00045	0.00605	CcSEcCtD
Diflunisal—Headache—Hydroxyurea—head and neck cancer	0.000448	0.00602	CcSEcCtD
Diflunisal—Decreased appetite—Fluorouracil—head and neck cancer	0.000447	0.00601	CcSEcCtD
Diflunisal—Flurbiprofen—PTGS2—head and neck cancer	0.000444	0.0317	CrCbGaD
Diflunisal—Muscle spasms—Docetaxel—head and neck cancer	0.000437	0.00588	CcSEcCtD
Diflunisal—Nausea—Hydroxyurea—head and neck cancer	0.000425	0.0057	CcSEcCtD
Diflunisal—Feeling abnormal—Fluorouracil—head and neck cancer	0.000424	0.0057	CcSEcCtD
Diflunisal—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—head and neck cancer	0.000421	0.0191	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—MMP8—head and neck cancer	0.00042	0.019	CbGpPWpGaD
Diflunisal—ALB—lymph node—head and neck cancer	0.000418	0.0132	CbGeAlD
Diflunisal—Urticaria—Fluorouracil—head and neck cancer	0.000409	0.00549	CcSEcCtD
Diflunisal—Syncope—Docetaxel—head and neck cancer	0.000408	0.00548	CcSEcCtD
Diflunisal—Body temperature increased—Fluorouracil—head and neck cancer	0.000407	0.00546	CcSEcCtD
Diflunisal—PTGS2—lymphoid tissue—head and neck cancer	0.000404	0.0128	CbGeAlD
Diflunisal—Palpitations—Docetaxel—head and neck cancer	0.000402	0.0054	CcSEcCtD
Diflunisal—Loss of consciousness—Docetaxel—head and neck cancer	0.0004	0.00537	CcSEcCtD
Diflunisal—Chest pain—Docetaxel—head and neck cancer	0.000387	0.0052	CcSEcCtD
Diflunisal—PTGS1—thyroid gland—head and neck cancer	0.000383	0.0121	CbGeAlD
Diflunisal—UGT1A8—Biological oxidations—GSTM1—head and neck cancer	0.000381	0.0173	CbGpPWpGaD
Diflunisal—Hypersensitivity—Fluorouracil—head and neck cancer	0.000379	0.00509	CcSEcCtD
Diflunisal—Confusional state—Docetaxel—head and neck cancer	0.000374	0.00503	CcSEcCtD
Diflunisal—Oedema—Docetaxel—head and neck cancer	0.000371	0.00499	CcSEcCtD
Diflunisal—Anaphylactic shock—Docetaxel—head and neck cancer	0.000371	0.00499	CcSEcCtD
Diflunisal—Shock—Docetaxel—head and neck cancer	0.000365	0.00491	CcSEcCtD
Diflunisal—Pruritus—Fluorouracil—head and neck cancer	0.000364	0.00489	CcSEcCtD
Diflunisal—Thrombocytopenia—Docetaxel—head and neck cancer	0.000364	0.00488	CcSEcCtD
Diflunisal—UGT1A8—Biological oxidations—CYP1A1—head and neck cancer	0.000361	0.0164	CbGpPWpGaD
Diflunisal—Anorexia—Docetaxel—head and neck cancer	0.000354	0.00476	CcSEcCtD
Diflunisal—Diarrhoea—Fluorouracil—head and neck cancer	0.000352	0.00473	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—BCL2—head and neck cancer	0.000347	0.0158	CbGpPWpGaD
Diflunisal—Dizziness—Fluorouracil—head and neck cancer	0.00034	0.00457	CcSEcCtD
Diflunisal—PTGS1—head—head and neck cancer	0.00034	0.0108	CbGeAlD
Diflunisal—PTGS2—C-MYB transcription factor network—CEBPA—head and neck cancer	0.000337	0.0153	CbGpPWpGaD
Diflunisal—Insomnia—Docetaxel—head and neck cancer	0.000336	0.00451	CcSEcCtD
Diflunisal—Paraesthesia—Docetaxel—head and neck cancer	0.000333	0.00448	CcSEcCtD
Diflunisal—Dyspnoea—Docetaxel—head and neck cancer	0.000331	0.00445	CcSEcCtD
Diflunisal—Somnolence—Docetaxel—head and neck cancer	0.00033	0.00444	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—PTGS2—head and neck cancer	0.00033	0.015	CbGpPWpGaD
Diflunisal—Vomiting—Fluorouracil—head and neck cancer	0.000327	0.00439	CcSEcCtD
Diflunisal—Dyspepsia—Docetaxel—head and neck cancer	0.000327	0.00439	CcSEcCtD
Diflunisal—PTGS2—head—head and neck cancer	0.000325	0.0103	CbGeAlD
Diflunisal—Rash—Fluorouracil—head and neck cancer	0.000324	0.00436	CcSEcCtD
Diflunisal—Dermatitis—Fluorouracil—head and neck cancer	0.000324	0.00435	CcSEcCtD
Diflunisal—Decreased appetite—Docetaxel—head and neck cancer	0.000323	0.00434	CcSEcCtD
Diflunisal—Headache—Fluorouracil—head and neck cancer	0.000322	0.00433	CcSEcCtD
Diflunisal—Fatigue—Docetaxel—head and neck cancer	0.00032	0.0043	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—UROD—head and neck cancer	0.000318	0.0144	CbGpPWpGaD
Diflunisal—Constipation—Docetaxel—head and neck cancer	0.000318	0.00427	CcSEcCtD
Diflunisal—Feeling abnormal—Docetaxel—head and neck cancer	0.000306	0.00411	CcSEcCtD
Diflunisal—Nausea—Fluorouracil—head and neck cancer	0.000306	0.00411	CcSEcCtD
Diflunisal—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000304	0.00408	CcSEcCtD
Diflunisal—PTGS2—C-MYB transcription factor network—CCNA1—head and neck cancer	0.000297	0.0135	CbGpPWpGaD
Diflunisal—Body temperature increased—Docetaxel—head and neck cancer	0.000294	0.00394	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—BCL2—head and neck cancer	0.000276	0.0125	CbGpPWpGaD
Diflunisal—PTGS1—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.000274	0.0124	CbGpPWpGaD
Diflunisal—Hypersensitivity—Docetaxel—head and neck cancer	0.000274	0.00368	CcSEcCtD
Diflunisal—Asthenia—Docetaxel—head and neck cancer	0.000266	0.00358	CcSEcCtD
Diflunisal—Pruritus—Docetaxel—head and neck cancer	0.000263	0.00353	CcSEcCtD
Diflunisal—PTGS1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000259	0.0117	CbGpPWpGaD
Diflunisal—PTGS1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000256	0.0116	CbGpPWpGaD
Diflunisal—Diarrhoea—Docetaxel—head and neck cancer	0.000254	0.00341	CcSEcCtD
Diflunisal—Dizziness—Docetaxel—head and neck cancer	0.000246	0.0033	CcSEcCtD
Diflunisal—PTGS1—lymph node—head and neck cancer	0.000238	0.00753	CbGeAlD
Diflunisal—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000237	0.0107	CbGpPWpGaD
Diflunisal—Vomiting—Docetaxel—head and neck cancer	0.000236	0.00317	CcSEcCtD
Diflunisal—Rash—Docetaxel—head and neck cancer	0.000234	0.00315	CcSEcCtD
Diflunisal—Dermatitis—Docetaxel—head and neck cancer	0.000234	0.00314	CcSEcCtD
Diflunisal—Headache—Docetaxel—head and neck cancer	0.000233	0.00313	CcSEcCtD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.000229	0.0104	CbGpPWpGaD
Diflunisal—TTR—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000229	0.0104	CbGpPWpGaD
Diflunisal—PTGS2—lymph node—head and neck cancer	0.000228	0.0072	CbGeAlD
Diflunisal—Nausea—Docetaxel—head and neck cancer	0.000221	0.00296	CcSEcCtD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000217	0.00985	CbGpPWpGaD
Diflunisal—PTGS2—S1P1 pathway—VEGFA—head and neck cancer	0.000206	0.00936	CbGpPWpGaD
Diflunisal—PTGS2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000205	0.00931	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.000203	0.00923	CbGpPWpGaD
Diflunisal—PTGS2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000203	0.00922	CbGpPWpGaD
Diflunisal—PTGS2—S1P1 pathway—MAPK3—head and neck cancer	0.000195	0.00886	CbGpPWpGaD
Diflunisal—PTGS2—S1P1 pathway—MAPK1—head and neck cancer	0.000186	0.00843	CbGpPWpGaD
Diflunisal—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000179	0.00813	CbGpPWpGaD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—head and neck cancer	0.000173	0.00785	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000172	0.00782	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.000171	0.00777	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000164	0.00746	CbGpPWpGaD
Diflunisal—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000152	0.0069	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—GSTM1—head and neck cancer	0.000142	0.00642	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—SOD2—head and neck cancer	0.000139	0.00632	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000137	0.00621	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000136	0.00616	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—GPX1—head and neck cancer	0.000133	0.00603	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—NAT2—head and neck cancer	0.000132	0.00598	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—CDH1—head and neck cancer	0.000132	0.00597	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000131	0.00592	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000124	0.00561	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000116	0.00527	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—DPYD—head and neck cancer	0.000116	0.00525	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.000112	0.00508	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000111	0.00502	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—YAP1—head and neck cancer	0.00011	0.00498	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000106	0.00479	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000102	0.00461	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.0001	0.00456	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	9.68e-05	0.00439	CbGpPWpGaD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	9.57e-05	0.00434	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	9.53e-05	0.00432	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KISS1—head and neck cancer	9.24e-05	0.00419	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	9.16e-05	0.00415	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	9.16e-05	0.00415	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—BCL2—head and neck cancer	8.4e-05	0.00381	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—UROD—head and neck cancer	8.38e-05	0.0038	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GRP—head and neck cancer	7.61e-05	0.00345	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	7.42e-05	0.00337	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT6—head and neck cancer	7.39e-05	0.00335	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	7.35e-05	0.00333	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL2—head and neck cancer	7.26e-05	0.00329	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—CCND1—head and neck cancer	7.21e-05	0.00327	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—UROD—head and neck cancer	6.65e-05	0.00302	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—TYMS—head and neck cancer	6.59e-05	0.00299	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—YAP1—head and neck cancer	6.54e-05	0.00297	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GSTM1—head and neck cancer	6.52e-05	0.00296	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.5e-05	0.00295	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GPX1—head and neck cancer	6.24e-05	0.00283	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	6.22e-05	0.00282	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CYP1A1—head and neck cancer	6.18e-05	0.0028	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	6.04e-05	0.00274	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL2—head and neck cancer	5.63e-05	0.00256	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCND1—head and neck cancer	5.49e-05	0.00249	CbGpPWpGaD
Diflunisal—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	5.44e-05	0.00247	CbGpPWpGaD
Diflunisal—ALB—Metabolism—UROD—head and neck cancer	5.38e-05	0.00244	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—VEGFA—head and neck cancer	5.29e-05	0.0024	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.16e-05	0.00234	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	5.07e-05	0.0023	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	5.04e-05	0.00228	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—head and neck cancer	4.66e-05	0.00211	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	4.54e-05	0.00206	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	4.53e-05	0.00205	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.35e-05	0.00197	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	4.31e-05	0.00195	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	4.31e-05	0.00195	CbGpPWpGaD
Diflunisal—TTR—Disease—NOTCH1—head and neck cancer	4.21e-05	0.00191	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.18e-05	0.00189	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.74e-05	0.00169	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.69e-05	0.00168	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS2—head and neck cancer	3.67e-05	0.00167	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.66e-05	0.00166	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	3.62e-05	0.00164	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.61e-05	0.00164	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NAT2—head and neck cancer	3.48e-05	0.00158	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.26e-05	0.00148	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTEN—head and neck cancer	3.2e-05	0.00145	CbGpPWpGaD
Diflunisal—TTR—Disease—PTGS2—head and neck cancer	3.13e-05	0.00142	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.08e-05	0.0014	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—DPYD—head and neck cancer	3.05e-05	0.00138	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOTCH1—head and neck cancer	2.95e-05	0.00134	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.93e-05	0.00133	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.93e-05	0.00133	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.93e-05	0.00133	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.9e-05	0.00132	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—YAP1—head and neck cancer	2.9e-05	0.00131	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NAT2—head and neck cancer	2.76e-05	0.00125	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	2.76e-05	0.00125	CbGpPWpGaD
Diflunisal—TTR—Disease—PTEN—head and neck cancer	2.73e-05	0.00124	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.54e-05	0.00115	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.46e-05	0.00112	CbGpPWpGaD
Diflunisal—TTR—Disease—STAT3—head and neck cancer	2.44e-05	0.00111	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—DPYD—head and neck cancer	2.42e-05	0.0011	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.37e-05	0.00108	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.35e-05	0.00107	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	2.35e-05	0.00106	CbGpPWpGaD
Diflunisal—TTR—Disease—MAPK3—head and neck cancer	2.33e-05	0.00106	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—YAP1—head and neck cancer	2.3e-05	0.00104	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CA—head and neck cancer	2.26e-05	0.00103	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NAT2—head and neck cancer	2.23e-05	0.00101	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	2.22e-05	0.00101	CbGpPWpGaD
Diflunisal—TTR—Disease—MAPK1—head and neck cancer	2.22e-05	0.00101	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—head and neck cancer	2.22e-05	0.001	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.18e-05	0.000987	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	2.11e-05	0.000957	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.08e-05	0.000943	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—head and neck cancer	2.03e-05	0.00092	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—head and neck cancer	1.98e-05	0.000897	CbGpPWpGaD
Diflunisal—ALB—Metabolism—DPYD—head and neck cancer	1.96e-05	0.000889	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CA—head and neck cancer	1.92e-05	0.000872	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTEN—head and neck cancer	1.91e-05	0.000866	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.9e-05	0.00086	CbGpPWpGaD
Diflunisal—ALB—Metabolism—YAP1—head and neck cancer	1.86e-05	0.000843	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—AKT1—head and neck cancer	1.85e-05	0.000837	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.83e-05	0.000831	CbGpPWpGaD
Diflunisal—TTR—Disease—HRAS—head and neck cancer	1.78e-05	0.000807	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TYMS—head and neck cancer	1.74e-05	0.000788	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—head and neck cancer	1.72e-05	0.000782	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTM1—head and neck cancer	1.72e-05	0.000779	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—head and neck cancer	1.71e-05	0.000774	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GPX1—head and neck cancer	1.65e-05	0.000746	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK3—head and neck cancer	1.63e-05	0.00074	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1A1—head and neck cancer	1.63e-05	0.000739	CbGpPWpGaD
Diflunisal—TTR—Disease—AKT1—head and neck cancer	1.57e-05	0.000712	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK1—head and neck cancer	1.55e-05	0.000704	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—head and neck cancer	1.55e-05	0.000704	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.51e-05	0.000683	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.5e-05	0.000679	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—head and neck cancer	1.42e-05	0.000645	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.4e-05	0.000634	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TYMS—head and neck cancer	1.38e-05	0.000626	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTM1—head and neck cancer	1.36e-05	0.000619	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CA—head and neck cancer	1.35e-05	0.000611	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.34e-05	0.000607	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GPX1—head and neck cancer	1.31e-05	0.000593	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—head and neck cancer	1.3e-05	0.000591	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1A1—head and neck cancer	1.29e-05	0.000587	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HRAS—head and neck cancer	1.25e-05	0.000565	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOTCH1—head and neck cancer	1.24e-05	0.000561	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.22e-05	0.000553	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—head and neck cancer	1.21e-05	0.000548	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK3—head and neck cancer	1.14e-05	0.000519	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TYMS—head and neck cancer	1.12e-05	0.000506	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTM1—head and neck cancer	1.1e-05	0.000501	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AKT1—head and neck cancer	1.1e-05	0.000499	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK1—head and neck cancer	1.09e-05	0.000493	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.06e-05	0.000482	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GPX1—head and neck cancer	1.06e-05	0.000479	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1A1—head and neck cancer	1.05e-05	0.000475	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—head and neck cancer	9.69e-06	0.000439	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CA—head and neck cancer	9.44e-06	0.000428	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—head and neck cancer	9.13e-06	0.000414	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—HRAS—head and neck cancer	8.73e-06	0.000396	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.6e-06	0.00039	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTEN—head and neck cancer	8.45e-06	0.000383	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PTEN—head and neck cancer	8.01e-06	0.000363	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—AKT1—head and neck cancer	7.71e-06	0.00035	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—head and neck cancer	7.16e-06	0.000325	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAPK3—head and neck cancer	6.84e-06	0.00031	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTEN—head and neck cancer	6.71e-06	0.000304	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAPK1—head and neck cancer	6.51e-06	0.000295	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—head and neck cancer	6.51e-06	0.000295	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—head and neck cancer	6.22e-06	0.000282	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CA—head and neck cancer	5.96e-06	0.00027	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CA—head and neck cancer	5.65e-06	0.000256	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTEN—head and neck cancer	5.43e-06	0.000246	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HRAS—head and neck cancer	5.23e-06	0.000237	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AKT1—head and neck cancer	4.87e-06	0.000221	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CA—head and neck cancer	4.73e-06	0.000215	CbGpPWpGaD
Diflunisal—PTGS2—Disease—AKT1—head and neck cancer	4.62e-06	0.000209	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AKT1—head and neck cancer	3.87e-06	0.000175	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CA—head and neck cancer	3.83e-06	0.000174	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AKT1—head and neck cancer	3.13e-06	0.000142	CbGpPWpGaD
